Back to top
more

Axon Enterprise (AXON)

(Delayed Data from NSDQ)

$863.65 USD

863.65
841,984

-3.47 (-0.40%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $863.65 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (144 out of 246)

Industry: Aerospace - Defense Equipment

Zacks News

Zacks Equity Research

Implied Volatility Surging for Axovant Sciences (AXON) Stock Options

Axovant Sciences (AXON) warrants investors' attention based on moves in the options market lately.

    Zacks Equity Research

    Implied Volatility Surging for Axovant Sciences (AXON) Stock Options

    Investors in Axovant Sciences Ltd. (AXON) need to pay close attention to the stock based on moves in the options market lately.

      Zacks Equity Research

      Arena Pharmaceuticals (ARNA) Posts Q1 Loss, Revenues Down

      Arena Pharmaceuticals, Inc. (ARNA) reported loss of 9 cents per share in the first quarter of 2017, same as in the year-ago period but wider than the Zacks Consensus Estimate of a loss of 8 cents.

        Zacks Equity Research

        Implied Volatility Surging for Axovant Sciences (AXON) Stock Options

        Axovant Sciences (AXON) warrants investors' attention based on moves in the options market lately.

          Debasmita Banerjee headshot

          Axovant Sciences (AXON) Shows Strength: Stock Jumps 9.2%

          Axovant Sciences Ltd. (AXON) shares rose a little above 9% in the last trading session.

            Zacks Equity Research

            Is the Options Market Predicting a Spike in Axovant Sciences (AXON) Stock?

            Options traders are pricing in a big move for Axovant Sciences (AXON) shares as it has huge implied volatility.

              Zacks Equity Research

              The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences

              The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant Sciences

                Zacks Equity Research

                Implied Volatility Surging for Axovant Sciences (AXON) Stock Options

                Axovant Sciences (AXON) warrants investors' attention based on moves in the options market lately.